Beik J, Abed Z, Ghoreishi FS, Hosseini-Nami S, Mehrzadi S, Shakeri-Zadeh A, Kamrava SK. Nanotechnology in hyperthermia most cancers remedy: from elementary ideas to superior functions. J Management Launch. 2016;235:205–21.
Turgeon G-A, Weickhardt A, Azad AA, Solomon B, Siva S. Radiotherapy and immunotherapy: a synergistic impact in most cancers care. Med J Aust. 2019;210(1):47–53.
Williamson CW, Sherer MV, Zamarin D, Sharabi AB, Dyer BA, Mell LK, Mayadev JS. Immunotherapy and radiation remedy sequencing: state of the info on timing, efficacy, and security. Most cancers. 2021;127(10):1553–67.
Yu W-D, Solar G, Li J, Xu J, Wang X. Mechanisms and therapeutic potentials of most cancers immunotherapy together with radiotherapy and/or chemotherapy. Most cancers Lett. 2019;452:66–70.
Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TYM, et al. Increasing international entry to radiotherapy. Lancet Oncol. 2015;16(10):1153–86.
Whiteside TL. The tumor microenvironment and its function in selling tumor progress. Oncogene. 2008;27(45):5904–12.
Wu T, Dai Y. Tumor microenvironment and therapeutic response. Most cancers Lett. 2017;387:61–8.
Trédan O, Galmarini CM, Patel Ok, Tannock IF. Drug resistance and the strong tumor microenvironment. JNCI: J Natl Most cancers Inst. 2007;99(19):1441–54.
Withers HR. The 4 R’s of radiotherapy. In: Lett JT, Adler H, editors. Advances in radiation biology, vol. 5. Amsterdam: Elsevier; 1975. p. 241–71.
Formenti SC, Demaria S. Systemic results of native radiotherapy. Lancet Oncol. 2009;10(7):718–26.
De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F. Radiotherapy toxicity. Nat Rev Dis Primers. 2019;5(1):13.
Farhood B, Goradel NH, Mortezaee Ok, Khanlarkhani N, Salehi E, Nashtaei MS, Mirtavoos-mahyari H, Motevaseli E, Shabeeb D, Musa AE, et al. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clin Transl Oncol. 2019;21(3):268–79.
Yang L, Du X, Qin Y, Wang X, Zhang L, Chen Z, Wang Z, Yang X, Lei M, Zhu Y. Biomimetic multifunctional nanozymes enhanced radiosensitization for breast most cancers by way of an X-ray triggered cascade response. J Mater Chem B. 2022;10(19):3667–80.
He Z, Yan H, Zeng W, Yang Ok, Rong P. Tumor microenvironment-responsive multifunctional nanoplatform primarily based on MnFe2O4-PEG for enhanced magnetic resonance imaging-guided hypoxic most cancers radiotherapy. J Mater Chem B. 2021;9(6):1625–37.
Werner ME, Cummings ND, Sethi M, Wang EC, Sukumar R, Moore DT, Wang AZ. Preclinical analysis of genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the remedy of non-small cell lung most cancers. Int J Radiat Oncol Biol Phys. 2013;86(3):463–8.
Wang AZ, Tepper JE. Nanotechnology in radiation oncology. J Clin Oncol: Off J Am Soc Clin Oncol. 2014;32(26):2879–85.
Orth M, Unger Ok, Schoetz U, Belka C, Lauber Ok. Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2. Oncogene. 2018;37(1):52–62.
Gill MR, Vallis KA. Transition metallic compounds as most cancers radiosensitizers. Chem Soc Rev. 2019;48(2):540–57.
Deng Z, Yu L, Cao W, Zheng W, Chen T. A selenium-containing ruthenium complicated as a most cancers radiosensitizer, rational design and the essential function of ROS-mediated signalling. Chem Commun. 2015;51(13):2637–40.
Bennie LA, Feng J, Emmerson C, Hyland WB, Matchett KB, McCarthy HO, Coulter JA. Formulating RALA/Au nanocomplexes to boost nanoparticle internalisation effectivity, sensitising prostate tumour fashions to radiation remedy. J Nanobiotechnol. 2021;19(1):279.
Li X, Yu Y, Chen Q, Lin J, Zhu X, Liu X, He L, Chen T, He W. Engineering most cancers cell membrane-camouflaged metallic complicated for environment friendly focusing on remedy of breast most cancers. Nanobiotechnol. 2022;20(1):401.
Xie J, Gong L, Zhu S, Yong Y, Gu Z, Zhao Y. Rising methods of nanomaterial-mediated tumor radiosensitization. Adv Mater. 2019;31(3):1802244.
Gong L, Zhang Y, Liu C, Zhang M, Han S. Utility of radiosensitizers in most cancers radiotherapy. Int J Nanomed. 2021;16:1083–102.
Su XY, Liu PD, Wu H, Gu N. Enhancement of radiosensitization by metal-based nanoparticles in most cancers radiation remedy. Most cancers Biol Med. 2014;11(2):86–91.
Zhu S, Gu Z, Zhao Y. Harnessing tumor microenvironment for nanoparticle-mediated radiotherapy. Adv Ther. 2018;1(5):1800050.
Chang Y, He L, Li Z, Zeng L, Tune Z, Li P, Chan L, You Y, Yu X-F, Chu PK, et al. Designing core-shell gold and selenium nanocomposites for most cancers radiochemotherapy. ACS Nano. 2017;11(5):4848–58.
Jin J, Zhao Q. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: current advances and future challenges. J Nanobiotechnol. 2020;18(1):75.
Tune Z, Liu T, Lai H, Meng X, Yang L, Su J, Chen T. A Universally EDTA-assisted synthesis of polytypic bismuth telluride nanoplates with a size-dependent enhancement of tumor radiosensitivity and metabolism in vivo. ACS Nano. 2022;16(3):4379–96.
Jiang W, Wei L, Chen B, Luo X, Xu P, Cai J, Hu Y. Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy. J Nanobiotechnol. 2022;20(1):129.
Solar H, Cai H, Xu C, Zhai H, Lux F, Xie Y, Feng L, Du L, Liu Y, Solar X, et al. AGuIX nanoparticles improve ionizing radiation-induced ferroptosis on tumor cells by focusing on the NRF2-GPX4 signaling pathway. J Nanobiotechnol. 2022;20(1):449.
Zhou X, You M, Wang F, Wang Z, Gao X, Jing C, Liu J, Guo M, Li J, Luo A, et al. Multifunctional graphdiyne-cerium oxide nanozymes facilitate microrna supply and attenuate tumor hypoxia for extremely environment friendly radiotherapy of esophageal most cancers. Adv Mater. 2021;33(24):2100556.
Gao Y, Chen Ok, Ma JL, Gao F. Cerium oxide nanoparticles in most cancers. Onco Targets Ther. 2014;7:835–40.
Lord MS, Berret JF, Singh S, Vinu A, Karakoti AS. Redox Lively cerium oxide nanoparticles: present standing and burning points. Small. 2021;17(51):2102342.
Mi Y, Shao Z, Vang J, Kaidar-Particular person O, Wang AZ. Utility of nanotechnology to most cancers radiotherapy. Most cancers Nanotechnol. 2016;7(1):11.
Brahimi-Horn MC, Chiche J, Pouysségur J. Hypoxia and most cancers. J Mol Med. 2007;85(12):1301–7.
You Y, Zhao Z, He L, Solar Z, Zhang D, Shi C, Cheng Q, Liu Y, Luo L, Chen T. Lengthy-term oxygen storage nanosystem for near-infrared light-triggered oxygen provides to antagonize hypoxia-induced therapeutic resistance in nasopharyngeal carcinoma. Adv Func Mater. 2020;30(27):2002369.
Liu Y, Lin W, Yang F, Chen T. Environment friendly catalysis of endogenous oxygen era for MRI-guided synergistic photodynamic remedy by ternary nanostructure. Appl Mater At this time. 2022;28:101520.
Motealleh A, Kehr NS. Injectable oxygen-generating nanocomposite hydrogels with extended oxygen supply for enhanced cell proliferation underneath hypoxic and normoxic circumstances. J Mater Chem B. 2020;8(19):4195–201.
Wu B, Solar Z, Wu J, Ruan J, Zhao P, Liu Ok, Zhao C-X, Sheng J, Liang T, Chen D. Nanoparticle-stabilized oxygen microcapsules ready by interfacial polymerization for enhanced oxygen supply. Angew Chem Int Ed. 2021;60(17):9284–9.
Qin S, Xu Y, Li H, Chen H, Yuan Z. Current advances in in situ oxygen-generating and oxygen-replenishing methods for hypoxic-enhanced photodynamic remedy. Biomater Sci. 2022;10(1):51–84.
Liu C, Li M, Li P, Bai Y, Pang J, Fan L, Tian W. Ruthenium (II)-coordinated supramolecular metallodrug complicated realizing oxygen self-supply in situ for overcoming hypoxic tumors. Adv Func Mater. 2021;31(47):2105837.
Wu M, Chen T, Wang L, Akakuru OU, Ma X, Xu J, Hu J, Chen J, Fang Q, Wu A, et al. The technique of exact focusing on and in situ oxygenating for enhanced triple-negative breast most cancers chemophototherapy. Nanoscale. 2022;14(23):8349–61.
Liu J, Zhang J, Tune Ok, Du J, Wang X, Liu J, Li B, Ouyang R, Miao Y, Solar Y, et al. Tumor microenvironment modulation platform primarily based on composite biodegradable bismuth-manganese radiosensitizer for inhibiting radioresistant hypoxic tumors. Small. 2021;17(34):2101015.
Zhu Y, Jin D, Liu M, Dai Y, Li L, Zheng X, Wang L, Shen A, Yu J, Wu S, et al. Oxygen self-supply engineering-ferritin for the reduction of hypoxia in tumors and the enhancement of photodynamic remedy efficacy. Small. 2022;18(15):2200116.
Zhang M, Li B, Du Y, Zhou G, Tang Y, Shi Y, Zhang B, Xu Z, Huang Q. A novel clever PANI/ PPy@Au@MnO2 yolk−shell nanozyme for MRI-guided ‘triple-mode’ synergistic focused anti-tumor remedy. Chem Eng J. 2021;424:130356.
Xu X, Duan J, Liu Y, Kuang Y, Duan J, Liao T, Xu Z, Jiang B, Li C. Multi-stimuli responsive hole MnO2-based drug supply system for magnetic resonance imaging and mixed chemo-chemodynamic most cancers remedy. Acta Biomater. 2021;126:445–62.
Zhu SJ, Jia JQ, Wang T, Zhao D, Yang J, Dong F, Shang ZG, Zhang YX. Rational design of octahedron and nanowire CeO2@MnO2 core–shell heterostructures with excellent fee functionality for uneven supercapacitors. Chem Commun. 2015;51(80):14840–3.
